SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

SomnoMed Limited

SomnoMed offers oral appliances designed to treat obstructive sleep apnea. These devices are intended to move the jaw and tongue forward during sleep to open up the airway.

Metric
Company Name	SomnoMed Limited
Symbol	SOM
MSH ID	COM:SOMNOMED
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	AU
Stage
Employee Count	300
Website	somnomed.com/au
LinkedIn
Founders

Metric
Market Cap	49.71M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	58.56M
Revenue (LTM)
Revenue (NTM)
Gross Profit	31.54M
EBITDA	-1.62M
Operating Income	-5.31M
Net Income	-7.82M
EPS	-0.06
Diluted EPS	-0.06
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.54
Operating Profit Margin	-0.07
EBITDA Margin	-0.03
Net Profit Margin	-0.12
Return on Equity	-0.33
Return on Assets	-0.17
Return on Capital Employed	-0.14

COM:SOMNOMED

SomnoMed

Last Close

0.26

25/11 03:59

Market Cap

77.80M

Beta: -

Volume Today

101.60K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-4.75
P/B Ratio	1.67
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.14
EV Multiple	-26.35

Metric
Days Sales Outstanding	38.04
Days Payables Outstanding	144.99
Days Inventory Outstanding	53.58
Operating Cycle	94.98
Cash Conversion Cycle	-6.60
Asset Turnover	1.39

Metric
Operating Cash Flow	-4.05M
Free Cash Flow	-7.46M
Cash Flow to Debt	-0.35
Operating Cash Flow/Sales	-0.06
Free Cash Flow Yield	-0.14

Metric
Cash & Equivalents	10.34M
Accounts Receivable	-914.79K
Inventory	4.02M
Goodwill	4.05M
Debt to Capitalization	0.33
Debt to Assets	0.38
Current Ratio	1.50
Quick Ratio	1.45

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.01
SG&A to Revenue	0.16